Pfizer Races to Salvage Obesity Drugmaker Deal After Novo’s Bid – Bloomberg.com

Pfizer Races to Salvage Obesity Drugmaker Deal After Novo’s Bid  Bloomberg.comNovo Nordisk’s Metsera bid shows how far it’ll go to outpace competitors  AxiosNovo Nordisk changes tack with bold raid on Pfizer obesity deal  ReutersNovo Nordisk Seeks to Outmuscle Pfizer With $9 Billion Bid for Metsera  The Wall Street JournalNovo Nordisk’s new CEO is chasing the deals its former leaders wouldn’t  Endpoints News